000 01782 a2200541 4500
005 20250517081731.0
264 0 _c20180123
008 201801s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.7443
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Do Yeon
245 0 0 _aA novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
_h[electronic resource]
260 _bOncotarget
_cMar 2016
300 _a14791-802 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Proliferation
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGlycogen Synthase Kinase 3
_xgenetics
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aNeoplastic Stem Cells
_xdrug effects
650 0 4 _aPhosphorylation
650 0 4 _aProtein Kinase C
_xgenetics
650 0 4 _aTumor Cells, Cultured
650 0 4 _aXenograft Model Antitumor Assays
650 0 4 _abeta Catenin
_xgenetics
700 1 _aPark, Eun Young
700 1 _aChang, EunSun
700 1 _aKang, Hyeok-Gu
700 1 _aKoo, Yoonjin
700 1 _aLee, Eun Ji
700 1 _aKo, Je Yeong
700 1 _aKong, Hyun Kyung
700 1 _aChun, Kyung-Hee
700 1 _aPark, Jong Hoon
773 0 _tOncotarget
_gvol. 7
_gno. 12
_gp. 14791-802
856 4 0 _uhttps://doi.org/10.18632/oncotarget.7443
_zAvailable from publisher's website
999 _c25750814
_d25750814